Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Tacrine hydrochloride hydrate: Precision in Alzheimer’s Rese
2026-06-23
Tacrine hydrochloride hydrate (Tetrahydroaminacrine) remains a gold-standard tool for dissecting cholinergic signaling and neurodegenerative mechanisms in Alzheimer’s disease models. This article delivers advanced workflows, troubleshooting strategies, and translational insights that empower researchers to maximize assay fidelity and unlock next-generation applications with APExBIO’s high-purity compound.
-
EGCG Nanoparticle Radiosensitizers Enhance FLASH-RT Antitumo
2026-06-23
Xu et al. report that functionalized EGCG nanoparticles (BENPs) significantly boost the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT) by amplifying ROS-mediated DNA damage and strengthening antitumor immunity. This innovation addresses a critical limitation of FLASH-RT and may inform future cancer therapy strategies.
-
Metabolic Modulation Sensitizes Tumors to Ferroptosis and Cu
2026-06-22
This study introduces a lipid-encapsulated nanosystem that synchronously enhances tumor cell susceptibility to both ferroptosis and cuproptosis by targeting glycolysis and NAD+ metabolism. The approach not only deepens regulated cell death but also remodels the tumor immune microenvironment, offering a promising direction for advanced cancer therapy.
-
VX-661: Enhancing F508del CFTR Correction in Cystic Fibrosis
2026-06-22
VX-661 (F508del CFTR corrector) delivers precise, reproducible rescue of misfolded CFTR in cystic fibrosis research, with advanced workflows informed by calnexin-dependent modulation. Explore evidence-based parameters, troubleshooting, and variant-specific strategies for robust CFTR trafficking and functional recovery.
-
Talabostat Mesylate (PT-100): Protocols for Tumor Microenvir
2026-06-21
Talabostat mesylate (PT-100) offers precise DPP4 and FAP inhibition, enabling researchers to dissect tumor microenvironments and amplify T-cell immunity in translational cancer models. This guide details optimized experimental workflows, troubleshooting strategies, and insights from recent inflammasome research to drive reproducibility and innovation.
-
Asunaprevir (BMS-650032): Optimizing HCV RNA Replication Inh
2026-06-20
Asunaprevir (BMS-650032) stands out for its robust, genotype-spanning inhibition of HCV NS3 protease and superior cellular uptake, empowering researchers to model hepatitis C virus infection with precision. This guide details advanced use-cases, stepwise workflows, and troubleshooting strategies to maximize reproducibility and data quality in antiviral research.
-
BMS-345541 Hydrochloride: Selective IKK Inhibition in Transl
2026-06-19
Explore how BMS-345541 hydrochloride, a selective IKK inhibitor, is revolutionizing translational inflammation and cancer biology research. This article uniquely bridges advanced mechanistic insights and practical workflow strategies for researchers aiming to dissect NF-κB signaling and overcome chemoresistance.
-
HyperFluor 488 Goat Anti-Human IgG Antibody: Applied Immunoa
2026-06-19
The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody from APExBIO stands out for its unparalleled sensitivity and versatility across immunofluorescence, Western blotting, and flow cytometry. By combining high specificity with robust Alexa Fluor 488 signal amplification, this polyclonal secondary antibody empowers reproducible, multiplexed human immunoglobulin detection in even the most demanding translational workflows.
-
Reactive Oxygen Species Assay Kit: Decoding Cellular Stress
2026-06-18
Explore the power of the Reactive Oxygen Species Assay Kit for precise ROS quantification in live cells. Uncover unique scientific insights, advanced protocol guidance, and evidence from translational lung disease research.
-
Caspase-4 Colorimetric Assay Kit: Precision Tools for ER-Dri
2026-06-18
Discover how the Caspase-4 Colorimetric Assay Kit empowers advanced ER-targeted cell fate studies. Explore its unique role in quantifying caspase-4 activity and its impact on inflammasome and pyroptosis research.
-
2-Hydroxypropyl-β-cyclodextrin: Technical Use and Parameters
2026-06-17
2-Hydroxypropyl-β-cyclodextrin (SKU B6413) addresses solubility challenges in pharmaceutical and biochemical research by forming inclusion complexes with hydrophobic compounds, particularly those containing aromatic or phenyl groups. It is validated for use as a drug formulation excipient and solubility enhancer, but applications beyond these roles are not supported by current documentation.
-
ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in
2026-06-17
This study uncovers ALDOB lysine-87 lactylation as a driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By elucidating a lactate–ALDOB–DRP1 axis in smooth muscle cells, the findings clarify molecular mechanisms underlying vascular remodeling and highlight new intervention targets.
-
Calnexin Modulation of CFTR Variant Rescue by Correctors
2026-06-16
Tedman et al. systematically dissect how the ER chaperone calnexin tunes both the expression and corrector responsiveness of over 200 clinical CFTR variants. Their deep mutational scanning approach reveals domain- and variant-specific dependencies on calnexin for effective pharmacological rescue, particularly informing precision cystic fibrosis research and therapeutic development.
-
Octyl-α-ketoglutarate: A Precision Tool for Dissecting HIF-1
2026-06-16
Explore how Octyl-α-ketoglutarate, a prolyl hydroxylase substrate, empowers advanced studies of HIF-1α regulation and metabolic reprogramming in cancer. Discover actionable insights and new comparative perspectives for researchers investigating hypoxia signaling and TCA cycle dysfunction.
-
2',7'-Dichlorofluorescein Diacetate Probe in ROS Assays
2026-06-15
2',7'-Dichlorofluorescein diacetate empowers precise, quantitative intracellular ROS and oxidative stress assays across cancer and drug discovery models. This guide translates recent advances—including nanocarrier-enabled workflows—into actionable protocols and troubleshooting strategies for robust, reproducible results.